MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study

E. Houston, A. Kennedy, T. Rabinowitz, G. Rose, J. Boyd (Burlington, USA)

Meeting: 2025 International Congress

Keywords: Tardive dyskinesia(TD)

Category: Drug-Induced Movement Disorders

Objective: Our goal was to evaluate the feasibility, effectiveness, and acceptability of a remote consultation with a movement disorder neurologist to patients suspected to have a drug-induced movement disorder (DIMD).

Background: DIMDs can be persistent and disabling, making prevention critical; but these disorders are often under-reported, under-recognized and inappropriately managed. Research shows that telemedicine for movement disorders (e.g. Parkinson’s disease) is feasible and may provide similar care as in-person visits; however, further validation in other movement disorders is necessary.

Method: Mental health clinicians referred patients with DIMDs to have a consultation and they were randomized to in-person or telemedicine visits. They had two visits, four to six months apart, and the neurologist provided their impression and care recommendations. We applied mixed methods to comprehensively assess factors that may impact feasibility, effectiveness, and acceptability of the program. Participants were invited to complete surveys about their well-being and experience, and mental health clinicians gave feedback using a survey and qualitative interviews.

Results: At visit 1, 79% of in-person participants completed a visit, compared to 86% of telemedicine participants. Visit 2 was successfully completed by 71% of in-person participants and 57% of telemedicine participants. One person in the telemedicine group withdrew due to technical poor video quality, and no other technical difficulties were reported. The neurologists felt confident in their ability to examine the participants remotely. Patient reported outcomes did not change between the two visits for either group, and many mental health clinicians (63%) agreed that the consultation improved care for the patient. Satisfaction scores were high among both participant groups after visit 1 (mean=29.9 in-person; 27.5 telemedicine), but the value fell for the telemedicine group following visit 2 (mean=30.7 in-person, 24.4 telemedicine). All mental health clinicians indicated that they would use a consultation service like this in the future. Main themes from their interviews related to acceptance within their practices, were resources and patient factors.

Conclusion: A consult service through telemedicine is feasible, effective, and acceptable, and can bridge the care gap between psychiatry and neurology in a rural location.

To cite this abstract in AMA style:

E. Houston, A. Kennedy, T. Rabinowitz, G. Rose, J. Boyd. Bridging the Care Gap for Individuals with Drug-Induced Movement Disorders Using Telemedicine: A Randomized Pilot Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/bridging-the-care-gap-for-individuals-with-drug-induced-movement-disorders-using-telemedicine-a-randomized-pilot-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/bridging-the-care-gap-for-individuals-with-drug-induced-movement-disorders-using-telemedicine-a-randomized-pilot-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley